Starling Oncology, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Starling Oncology, Inc. (DFPH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of -0.16% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-12
- Starling Oncology, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was -0.16%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | -0.16% 10-K · filed 2026-03-12 |